Cue Biopharma CMO Matteo Levisetti to depart Nov 28; gets $556,838 severance

Cue Biopharma, Inc.

Chief Medical Officer Matteo Levisetti will terminate employment effective November 28, 2025.
Severance includes lump sum of $556,837.60 (nine months base salary plus prorated 2025 bonus).
COBRA premiums paid by company for up to nine months post-separation if elected.
Payment conditioned on execution and nonrevocation of a separation and release agreement.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.